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Objective
To evaluate the prevalence of thrombotic and non-throm-
botic clinical manifestations and long-term outcome in a
large group of children with positive antiphospholipid
antibodies (aPL).
Methods
We retrospectively reviewed medical records from January
1997 to November 2007 at University Children's Hospital
Ljubljana for all patients who tested positive for aPL. Test-
ing for aPL was requested by the treating physician given
the clinical suspicion of aPL-related manifestations. All
patients fulfilled the consensus laboratory criteria for
antiphospholipid syndrome.
Results
We identified 190 aPL-positive patients and randomly
selected 100 patients for detailed evaluation. Sixty-two
were girls and 38 boys with mean age at presentation 9.7
years. Twenty-seven (27%) patients had underlying sys-
temic autoimmune disease (SLE 16, JIA 8). Sixty patients
presented with one, 14 with two and 13 with three or
more aPL-related clinical manifestations. Thromboses
occurred in 10 (10%) patients and one patient had recur-
rent thrombosis. One or more non-thrombotic clinical
manifestations were found in 77 (77%) patients includ-
ing hematological disorders in 27 (thrombocytopenia 20,
autoimmune hemolytic anemia 2), neurological disorders
in 26 (migraine 15, seizures 3, chorea 2) and skin disor-
ders in 22 patients (livedo reticularis 9, Raynaud's phe-
nomenon 4). Seventeen infants born to mothers with
aPL-positive autoimmune disease had positive aPL and 4
of them exhibited aPL-related clinical manifestations.
Conclusion
In our cohort, thrombotic events occurred only in 10% of
all symptomatic patients with positive aPL evaluated at
the tertiary care pediatric hospital. The most common
non-thrombotic manifestations found in children with
aPL were thrombocytopenia, migraine headache and
livedo reticularis.
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